For citations:
Romanenko V.V., Namazova-Baranova L.S., Kotova A.A., Efendieva K.E., Ruleva A.A., Khait E.A., Perminova O.A., Pak T.E., Lazareva S.G., Aleshina L.V., Suprun D.A., Galustyan A.N., Rychkova O.A., Romanova T.A., Aminova A.I., Dulova G.V. Results of a clinical study of the influenza tetravalent inactivated subunit adjuvant vaccine Grippol Quadrivalent in children aged 6 months to 5 years (inclusive). Pediatric pharmacology. 2024;21(3):213-225. (In Russ.) https://doi.org/10.15690/pf.v21i3.2743
JATS XML
Email this article 